NCT04619004 2026-04-07HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung CancerDaiichi SankyoPhase 2 Active not recruiting277 enrolled 16 charts
NCT06106802 2026-02-23Lazertinib & Tepotinib for EGFR Mutant NSCLC in MET Overexpressed or Amplified Who Progressed After Lazertinib TreatmentSamsung Medical CenterPhase 2 Recruiting47 enrolled